Medium Risk

Jupiter Life Line Hospitals Limited

Hospital activities

CIN: L85100MH2002PLC137908 FY: - Revenue: ₹1,060.0 Cr
5.3
ESG Risk
Score /10
Compliance RiskEpr ExposureGhg Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
1.0
EPR Exposure
6.5
Compliance Risk
10.0
HR Risk
5.0
Governance Risk
3.0

Financial Exposure

Est. Compliance Cost₹2–6 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated462.4 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyYes
BRSR AssuranceNone
Assurance Provider

Double Materiality

Financial Materiality5.3
Impact Materiality5.1
QuadrantDual Materiality

Supply Chain

MSME Sourcing0.5%
Lifecycle AssessmentNo
Product ReclaimYes

Material Risks

e-waste

ESG Targets & Commitments

TopicTarget / MetricStatus
Human Rights in Supply Chain HR clauses in all contracts Commitment

AI Risk Summary

**Financial Risk Summary: Jupiter Life Line Hospitals Limited** Jupiter Life Line faces critical compliance exposure with a maximum 10.0/10 compliance risk score and estimated remediation costs of ₹2–6 crore under SEBI BRSR Core Expansion mandates, creating potential delisting risk if non-conformance persists across top-tier disclosure requirements. The hospital's biggest financial vulnerability is EPR (Extended Producer Responsibility) exposure at 6.5/10—applicable to biomedical waste and medical device packaging—yet the company has not clarified EPR applicability status, risking unquantified liability under Plastic Waste Management Rules 2016 and Biomedical Waste Management Rules 2016. Water and GHG intensity risks (both 5.0/10) are material for a healthcare facility; with missing Scope 1 & 2 emissions data despite ₹1,060 crore revenue, the hospital cannot leverage India's CCTS pricing signal (₹600–900/tonne CO2e) for carbon offset planning or risk hedging. Immediate action required: complete ESG data disclosure

Source: Jupiter Life Line Hospitals Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →